“…Specifically, HEAQ was used at doses of 8 grams per day as an effective antibacterial compound from 1936 to 1939 in the treatment of over 500 pneumonia cases in Pittsburgh, PA, resulting in a 50% reduction in mortality, with no visual disturbances or severe adverse effects, including atrial fibrillation, noted for the drug (12)(13)(14). Additional studies confirmed the lower toxicity of HEAQ than quinine and other alkaloids such as ethylapocupreine, showing no visual toxicity in dogs (15). Hegner et al reported the efficacy of HEAQ in the treatment of three strains of bird malaria, demonstrating that HEAQ was as effective as but less potent than quinine against Plasmodium lophurae, P. relictum, and P. cathemerium (16)(17)(18).…”